Glenn Sloat, MD
Undersea and Hyperbaric Medicine · Albany, NYNPI 1922195429
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.8% of the total across 107 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by Organogenesis Inc. at 26.7% of the total. Reporting peaked in 2019 at $1,453 and has fallen 57.8% since, to $613 in 2025.
Across 107 payments — averaging $51.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$1K
- Smith+Nephew$1K
- Hydrofera LLC$694
- Kerecis Limited$458
- Tactile Systems Technology Inc$346
- Integra Lifesciences Corporation$179
- plus $1K from 12 others
What the payments were for
- Travel & lodging$2314%
- Food & beverage$5,30796%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organogenesis Inc. | 24 | $1,478 |
| Smith+Nephew | 40 | $1,247 |
| Hydrofera LLC | 10 | $694 |
| Kerecis Limited | 4 | $458 |
| Tactile Systems Technology Inc | 5 | $346 |
| Integra Lifesciences Corporation | 4 | $179 |
| KCI USA, Inc. | 2 | $150 |
| Lifenet Health | 1 | $148 |
| Paratek Pharmaceuticals, Inc. | 2 | $142 |
| Mimedx Group, Inc. | 1 | $138 |
| Nevro Corp. | 1 | $135 |
| Advanced Oxygen Therapy Inc. | 1 | $99 |
| Medtronic | 1 | $95 |
| Aroa Biosurgery Incorporated | 7 | $88 |
| Osiris Therapeutics Inc. | 1 | $52 |
| Solventum Corporation | 1 | $34 |
| Misonix Inc | 1 | $29 |
| Hartmann USA, Inc. | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PuraPly$804
- Kerecis SurgiClose$632
- HYDROFERA BLUE$403
- Kerecis Omega3 Wound$278
- Kerecis GraftGuide$158
- FLEXITOUCH$151
- ACTITOUCH$151
- ENTRE$151
- TheraGenesis Wound Matrix$148
- Flexitouch Plus$144
- Entre Plus$144
- OMNIGRAFT$142
- PRIMATRIX$142
- MEDIHONEY$142
- TCC-EZ$142
- AMNIOEXCEL$142
- Grafix$138
- Oasis$138
- Stravix$138
- Omnia$135
How this compares
Too few undersea and hyperbaric medicine providers in New Yorkto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 33 | $23,739 |
| Doxycycline Hyclate | 27 | $385 |
| Triamcinolone Acetonide | 33 | $368 |
| Silver Sulfadiazine | 14 | $259 |
| Doxycycline Monohydrate | 11 | $202 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $1,247 | $23,73933 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few undersea and hyperbaric medicine providers in New Yorkon file to place this against a meaningful peer group, so we don't.
Other undersea and hyperbaric medicine in Albany
- Paula PonsFayetteville$178K
- Diego EscobarNew Rochelle$3K
- Kurt DischnerRockville Centre$2K
- James PfeiffRome$851
- Kausik KarValhalla$764
- Nicholas VaccariBrooklyn$569
- Peter SalzerPlainview$220
- Joan ChouSyracuse$147
- Peter MarianiSyracuse$53
- Aaron ZellSaratoga Springs$22
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.